Evidence for central nervous system glial cell plasticity in phenylketonuria

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 7, 1996, Pages 795-814

  Dyer, Charissa A ^a,b,c   Kendler, Ady ^d   Philibotte, Thomas ^a   Gardiner, Paula ^a   Cruz, Jonathan ^e   Levy, Harvey L ^c,e,f  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e New England Newborn Screening Program   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Glial fibrillary acidic protein; Gliosis; Myelin; Myelin basic protein; Myelin oligodendrocyte specific protein; Oligodendrocyte; Schwann cells

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; CYCLINE; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; MYELIN BASIC PROTEIN; PHENYLALANINE 4 MONOOXYGENASE;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; GLIA CELL; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL PLASTICITY; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PHENYLKETONURIA; PRIORITY JOURNAL; RNA PROBE; SCHWANN CELL; WHITE MATTER;

EID: 0029949925     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199607000-00005     Document Type: Article

References (53)

1. Allen IV, Kirk J. In: Adams JH, Duchen LW, eds. Greenfield's Neuropathology. 5th Ed. New York: Oxford University Press, 1992; 447-520
2. Politis MJ, Sternberger N, Ederle K, Spencer PS. Studies on the control of myelogenesis. J Neurosci 1982;2:1252-66
3. Wagner-Recio M, Toews AD, Morell P. Tellurium blocks cholesterol synthesis by inhibiting squalene metabolism: Preferential vulnerability to this metabolic block leads to PNS demyelination. J Neurochem 1991;57:1891-1901
4. Trapp BD, Hauer P, Lemke G. Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells. J Neurosci 1988;8:3515-21
5. Roberson MD, Toews AD, Goodrum JF, Morell P. Neurofilament and tubulin mRNA expression in Schwann cells. J Neurosci Res 1992;33:156-62
6. HPH-5: A mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci USA 1990;87:1965-67
7. Shedlovsky A, McDonald JD, Symula D, Dove WF. Mouse models of human phenylketonuria. Genetics 1993;143:1205-10
8. Takashima S, Becker LE, Nishimura M, Tanaka J. Developmental changes of glial fibrillary acidic protein and myelin basic protein in perinatal leukomalacia: Relationship to a predisposing factor. Brain and Development 1984;6:444-50
9. Godfraind C, Friedrich VL, Holmes KV, Dubois-Dalcq M. In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol 1989;109:2405-16
10. Armstrong RC, Friedrich VL Jr, Holmes KV, Dubois-Dalcq M. In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination. J Cell Biol 1990;113:393-403
11. Raff MC, Miller RH, Noble M. A glial progenitor that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 1983;303:390-96
12. Hill HB, Summer GK, Pender MW, Roszell NO. An automated procedure for blood phenylalanine. Clin Chem 1965;11:541
13. Rudy JL, Rutledge JC, Lewis SL. Phenylalanine and tyrosine in serum and elutes from dried blood spots as determined by reverse-phase liquid chromatography. Clin Chem 1987;33:1152
14. McCarthy K, DeVellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980;85:890-902
15. Rome LH, Bullock PN, Chiapelli F, Cardwell M, Adinolfi AM, Swanson D. Synthesis of a myelin-like membrane by oligodendrocytes in cultures. J Neurosci Res 1986;15:49-55
16. Poduslo SE, Curbeam R, Miller K, Reier P. Purification and characterization of cultures of oligodendroglia from rat brain. J Neurosci Res 1985;14:433-47
17. Suzumrua A, Bhat S, Eccleston PA, Lisak RP, Silberberg DH. The isolation and long-term culture of oligodendrocytes from newborn mouse brain. Brain Res 1984;324:379-83
18. Bottenstein JE. Growth requirements in vitro of oligodendrocyte cell lines and neonatal rat brain oligodendrocytes. PNAS 1986;83:1955-59
19. Bansal R, Stefansson K, Pfeiffer SE. Proligodendroblast antigen (POA), a developmental antigen expressed by AOO7/O4-positive oligodendrocyte progenitors prior to appearance of sulfatide and galactocerebrosides. J Neurochem 1992;58:2221-29
20. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 1989;24:548-57
21. Sommer I, Schachner M. Monoclonal antibodies (O1 and O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 1981;83:311-27
22. Dyer CA, Hickey WF, Geisert EE Jr. Myelin/oligodendrocyte-specific protein: A novel surface membrane protein that associates with microtubules. J Neurosci Res 1991;28:607-13
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-85
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-54
25. Mutter GL, Wolgemuth DJ. Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells. Proc Natl Acad Sci USA 1987;84:5301-5
26. Campagnoni AT. Molecular biology of myelin proteins from the central nervous system. J Neurochem 1988;51:1-14
27. 2+-calmodulin regulated effectors of microtubule stability in neuronal tissues. Biochim Biophys Acta 1992;1169:113-19
28. Dyer CA, Philibotte TM, Wolf MK, Billings-Gagliardi S. Myelin basic protein mediates extracellular signals that regulate microtubule stability in oligodendrocyte membrane sheets. J Neurosci Res 1994;39:97-107
29. Dyer CA, Philibotte TM, Billings-Bagliardi S, Wolf MK. Cytoskeleton in myelin basic protein-deficient shiverer oligodendrocytes. Dev Neurosci 1995;17:53-62
30. Silver J, Lorenz SE, Wahlsten D, Coughlin J. Axonal guidance during development of the great cerebral commissures: Descriptive and experimental studies, in vivo, on the role of preformed glial pathways. J Comp Neurol 1982;210:10-29
31. Takahashi T, Caviness VS Jr. PCNA-binding to DNA at the G1/S transition in proliferating cells of the developing cerebral wall. J Neurocytol 1993;22:1096-1102
32. Dyer CA. Novel oligodendrocyte transmembrane signaling systems: Investigations utilizing antibodies as ligands. Mol Neurobiol 1993;7:1-22
33. Dyer CA, Philibotte TM. A clone of the MOCH-1 glial tumor in culture: Multiple phenotypes expressed under different environmental conditions. J Neuropath Exp Neurol 1995;54:852-63
34. Prineas JW, Kwon EE, Goldenberg PZ, Cho ES, Sharer LR. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab Invest 1990;63:624-36
35. Wu E, Raine CS. Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions. Lab Invest 1992;67:88-99
36. Ghatak NR, Leshner RT, Price AC, Felton WL III. Remyelination in the human central nervous system. J Neuropath Exp Neur 1989;48:507-18
37. Ghatak NR. Occurrence of oligodendrocytes within astrocytes in demyelinating lesions. J Neuropath Exp Neur 1992;51:40-46
38. Latov N, Nilaver G, Zimmerman A, Hohnson WG, Silverman A-J, Defendini R, Cote L. Fibrillary astrocytes proliferate in response to brain injury. Dev Bio 1979;72:381-84
39. Menon VK, Landerholm TE. Intralesion injection of basic fibroblast growth factor alters glial reactivity to neural trauma. Exp Neurobiol 1994;129:142-54
40. Norton WT, Aquino DA, Hozumi I, Chiu FC, Brosnan CE Quantitative aspects of reactive gliosis: A review. Neurochem Res 1992;17:877-85
41. Eng LF, Ghirnidar RS. GFAP and astrogliosis. Brain Path 1994;4: 229-37
42. Butt AM, Ibrahim M, Rüge FM, Berry M. Biochemical subtypes of oligodendrocyte in the anterior medullary velum of the rat as revealed by the monoclonal antibody Rip. Glia 1995;14:185-97
43. Pfeiffer SE, Warrington AE, Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993;3:191-97
44. Castillo M, Zafra MF, Garcia-Peregrin E. Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia. Neurochem Res 1988;13:551-55
45. Castillo M, Iglesias J, Zafra MF, Garcia-Peregrin E. Inhibition of chick brain cholesterogenic enzymes by phenyl and phenolic derivatives of phenylalanine. Neurochem Internat 1991;1:8171-8174
46. Cox AD, Hisada MM, Buss JE, Der CJ. Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein. Mol Cell Biol 1992;12:2606-15
47. Cox AD, Der CJ. Protein prenylation: More than just glue? Curr Opin Cell Biol 1992;4:1008-16
48. Bolin LM, Verity AN, Silver JE, Shooter EM, Abrams JS. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995;64850-58
49. Thompson AJ, Tillotson S, Smith I, Kendall B, Moore SG, Brenton DP Brain MRI changes in phenylketonuria. Brain 1993;116:811-21
50. Shaw DWW, Maravilla KR, Weinberger E, Garretson J, Trahms CM, Scott CR. MR imaging in phenylketonuria. Am J Neuro Rad 1991;12:403-6
51. Thompson AJ, Smith I, Brenton D, Youl BD, Rylance G, Davidson DC, Kendall B, Lees AJ. Neurological deterioration in young adults with phenylketonura. Lancet 1990;336:602-5
52. Bick U, Fahrendorf G, Ludolph AC, Vassallo P, Weglage J, Ullrich K. Disturbed myelination in patients with treated hyperphenylalaninaemia: Evaluation with magnetic resonance imaging. Eur J Pediatr 1991;150:185-89
53. Walter JH, Tyfield LA, Holten JB, Johnson C. Biochemical control, genetic analysis and magnetic resonance imaging in patients with phenylketonuria. Eur J Pediatr 1993;152:882-87